Literature DB >> 19536192

A novel modifier of regulatory T cells.

Naganari Ohkura, Shimon Sakaguchi.   

Abstract

The receptor for the lipid mediator sphingosine 1-phosphate is critical for T cell trafficking. New data show that signaling mediated by this receptor critically controls the development, maintenance and suppressive activity of natural regulatory T cells that express the transcription factor Foxp3.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19536192     DOI: 10.1038/ni0709-685

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  12 in total

Review 1.  Toll-like receptors on regulatory T cells: expanding immune regulation.

Authors:  Roger P M Sutmuller; Mary E Morgan; Mihai G Netea; Oliver Grauer; Gosse J Adema
Journal:  Trends Immunol       Date:  2006-06-30       Impact factor: 16.687

Review 2.  FTY720: a most promising immunosuppressant modulating immune cell functions.

Authors:  Zhiren Zhang; Hermann J Schluesener
Journal:  Mini Rev Med Chem       Date:  2007-08       Impact factor: 3.862

Review 3.  Regulatory T cells and immune tolerance.

Authors:  Shimon Sakaguchi; Tomoyuki Yamaguchi; Takashi Nomura; Masahiro Ono
Journal:  Cell       Date:  2008-05-30       Impact factor: 41.582

4.  The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptors.

Authors:  Shawn G Payne; Carole A Oskeritzian; Rachael Griffiths; Preeti Subramanian; Suzanne E Barbour; Charles E Chalfant; Sheldon Milstien; Sarah Spiegel
Journal:  Blood       Date:  2006-09-28       Impact factor: 22.113

5.  Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1.

Authors:  Mehrdad Matloubian; Charles G Lo; Guy Cinamon; Matthew J Lesneski; Ying Xu; Volker Brinkmann; Maria L Allende; Richard L Proia; Jason G Cyster
Journal:  Nature       Date:  2004-01-22       Impact factor: 49.962

6.  CD28 costimulation is essential for human T regulatory expansion and function.

Authors:  Tatiana N Golovina; Tatiana Mikheeva; Megan M Suhoski; Nicole A Aqui; Victoria C Tai; Xiaochuan Shan; Ronghua Liu; R Robert Balcarcel; Nancy Fisher; Bruce L Levine; Richard G Carroll; Noel Warner; Bruce R Blazar; Carl H June; James L Riley
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

7.  Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells.

Authors:  W Gao; Y Lu; B El Essawy; M Oukka; V K Kuchroo; T B Strom
Journal:  Am J Transplant       Date:  2007-05-19       Impact factor: 8.086

8.  Cutting edge: the phosphoinositide 3-kinase p110 delta is critical for the function of CD4+CD25+Foxp3+ regulatory T cells.

Authors:  Daniel T Patton; Oliver A Garden; Wayne P Pearce; Louise E Clough; Clare R Monk; Eva Leung; Wendy C Rowan; Sara Sancho; Lucy S K Walker; Bart Vanhaesebroeck; Klaus Okkenhaug
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

9.  The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR.

Authors:  Guangwei Liu; Samir Burns; Gonghua Huang; Kelli Boyd; Richard L Proia; Richard A Flavell; Hongbo Chi
Journal:  Nat Immunol       Date:  2009-05-31       Impact factor: 25.606

10.  The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells.

Authors:  Sokol Haxhinasto; Diane Mathis; Christophe Benoist
Journal:  J Exp Med       Date:  2008-02-18       Impact factor: 14.307

View more
  3 in total

Review 1.  Kinase AKT controls innate immune cell development and function.

Authors:  Yan Zhang; Xiao Wang; Hui Yang; Huanrong Liu; Yun Lu; Limei Han; Guangwei Liu
Journal:  Immunology       Date:  2013-10       Impact factor: 7.397

2.  TSC1/2 signaling complex is essential for peripheral naïve CD8+ T cell survival and homeostasis in mice.

Authors:  Lianjun Zhang; Hongbing Zhang; Lanlan Li; Yi Xiao; Enyu Rao; Zhuang Miao; Hui Chen; Lina Sun; Hongran Li; Guangwei Liu; Yong Zhao
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

3.  Prediction of antiviral efficacy in patients with chronic hepatitis C by changes in forkhead box protein 3 levels.

Authors:  Jia-Bao Chang; Rong Xue; Zhen-Xian Zhou; Yan-Hong Feng; Wei-Wei Dai; Jie Qiu; Yong-Feng Yang
Journal:  Exp Ther Med       Date:  2014-04-08       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.